Cargando…

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease in the Western world. Twenty percent of NAFLD individuals develop chronic hepatic inflammation (non-alcoholic steatohepatitis, NASH) associated with cirrhosis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henao-Mejia, Jorge, Elinav, Eran, Jin, Cheng-Cheng, Hao, Liming, Mehal, Wajahat Z., Strowig, Till, Thaiss, Christoph A., Kau, Andrew L., Eisenbarth, Stephanie C., Jurczak, Michael J., Camporez, Joao-Paulo, Shulman, Gerald I., Gordon, Jeffrey I., Hoffman, Hal M., Flavell, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276682/ https://www.ncbi.nlm.nih.gov/pubmed/22297845 http://dx.doi.org/10.1038/nature10809

Ejemplares similares

NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells
por: Eisenbarth, Stephanie C., et al.
Publicado: (2012)

The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)

Adenosine is required for sustained inflammasome activation via the A(2A) receptor and the HIF-1α pathway
por: Ouyang, Xinshou, et al.
Publicado: (2013)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Innate instruction of adaptive immunity revisited: the inflammasome
por: Eisenbarth, Stephanie C, et al.
Publicado: (2009)

Smoking-induced microbial dysbiosis in health and disease
por: Shapiro, Hagit, et al.
Publicado: (2022)

Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome
por: Levy, Maayan, et al.
Publicado: (2015)

Chronobiomics: The Biological Clock as a New Principle in Host–Microbial Interactions
por: Thaiss, Christoph A., et al.
Publicado: (2015)

Metabolites: messengers between the microbiota and the immune system
por: Levy, Maayan, et al.
Publicado: (2016)

Inflammasome activation and regulation: toward a better understanding of complex mechanisms
por: Zheng, Danping, et al.
Publicado: (2020)

Mechanisms of liver fibrosis in metabolic syndrome
por: Mehal, Wajahat
Publicado: (2023)

Who is the scientist in bio-medical research, the author or the reviewer?
por: Mehal, Wajahat Z.
Publicado: (2014)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
por: Pierantonelli, Irene, et al.
Publicado: (2017)

Activation of adenosine receptor A(2A) increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb
por: Ahsan, Md. Kaimul, et al.
Publicado: (2014)

Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway
por: Liang, Yinji, et al.
Publicado: (2018)

Bilberry Anthocyanins Ameliorate NAFLD by Improving Dyslipidemia and Gut Microbiome Dysbiosis
por: Nakano, Hironobu, et al.
Publicado: (2020)

Effects of Royal Jelly on Gut Dysbiosis and NAFLD in db/db Mice
por: Kobayashi, Genki, et al.
Publicado: (2023)

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
por: Wan, Xingyong, et al.
Publicado: (2016)

Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
por: Pierantonelli, Irene, et al.
Publicado: (2017)

Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
por: Schneider, Kai Markus, et al.
Publicado: (2020)

Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome
por: Wynosky-Dolfi, Meghan A., et al.
Publicado: (2014)

Immunological mechanisms and therapeutic targets of fatty liver diseases
por: Wang, Hua, et al.
Publicado: (2020)

Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD
por: Huang, Qian, et al.
Publicado: (2022)

ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content
por: Camporez, João Paulo G., et al.
Publicado: (2015)

Malarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases
por: Tiemi Shio, Marina, et al.
Publicado: (2009)

Correction: Malarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases
por: Shio, Marina Tiemi, et al.
Publicado: (2009)

New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders
por: Jamshed, Fatima, et al.
Publicado: (2023)

The Gut Microbiome and Individual-Specific Responses to Diet
por: Leshem, Avner, et al.
Publicado: (2020)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Harnessing SmartPhones to Personalize Nutrition in a Time of Global Pandemic
por: Zmora, Niv, et al.
Publicado: (2021)

Human microbiome research: Growing pains and future promises
por: Puschhof, Jens, et al.
Publicado: (2023)

Upregulation of antimicrobial peptide expression in slc26a3-/- mice with colonic dysbiosis and barrier defect
por: Kini, Archana, et al.
Publicado: (2022)

An Erk/Cdk5 axis controls the diabetogenic actions of PPARγ
por: Banks, Alexander S., et al.
Publicado: (2014)

A leukocyte activation test identifies food items which induce release of DNA by innate immune peripheral blood leucocytes
por: Garcia-Martinez, Irma, et al.
Publicado: (2018)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Matsui, Masahiro, et al.
Publicado: (2021)

Nonnutritive sweeteners and glucose intolerance: Where do we go from here?
por: Nobs, Samuel Philip, et al.
Publicado: (2023)

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome
por: Sutterwala, Fayyaz S., et al.
Publicado: (2007)

Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice
por: Camporez, João Paulo, et al.
Publicado: (2017)

Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways
por: Yong, Zhang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvdid0ruojrn3lisgbqngdu815